FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Pancrelipase (ULTRESA) Delayed-Release Capsules
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Forest Laboratories, Inc. (New 01/05/2016)

Company Contact Information:
800-272-5525

Presentation Posting Date Related Information
4,000 USP units: bottles of 100 capsules (NDC 58914-006-10) 01/05/2016 The company has made a business decision to cease manufacturing of this product. Date of interruption of supply is June 2016.
13,800 USP units: bottles of 100 capsules (NDC 58914-003-10) 01/05/2016 The company has made a business decision to cease manufacturing of this product. Date of interruption of supply is June 2016.
20,700 USP units: bottles of 100 capsules (NDC 58914-019-10) 01/05/2016 The company has made a business decision to cease manufacturing of this product. Date of interruption of supply is June 2016.
23,000 USP units: bottles of 100 capsules (NDC 58914-005-10) 01/05/2016 The company has made a business decision to cease manufacturing of this product. Date of interruption of supply is June 2016.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English